Bladder injection of onabotulinumtoxinA for the treatment of urinary incontinence due to neurogenic detrusor overactivity has recently been approved by regulatory agencies in several EU countries and by the FDA in the United States. This is the first book to focus on the practical application of botulinum toxin (BoNT) in the genitourinary tract. It covers in detail applications of BoNT in the bladder and the prostate and pelvic floor, with reviews of the latest clinical series and techniques in both adults and children. Appendices containing easy-to-read instructions for patients...
Bladder injection of onabotulinumtoxinA for the treatment of urinary incontinence due to neurogenic detrusor overactivity has recently been approve...
The minimally invasive use of botulinum toxins (BoNT) in the lower urinary tract has changed treatment of difficult bladder, urethra and prostate conditions refractory to conventional therapy. This book examines the use of BoNT in the genitourinary tract.
The minimally invasive use of botulinum toxins (BoNT) in the lower urinary tract has changed treatment of difficult bladder, urethra and prostate cond...
